Literature DB >> 17376727

NOD-like receptors and human diseases.

Philip Rosenstiel1, Andreas Till, Stefan Schreiber.   

Abstract

NOD-like receptors are cytosolic proteins that contain a central nucleotide-binding oligomerization domain (NACHT), an N-terminal effector-binding domain and C-terminal leucine-rich repeats (LRRs). NOD-like receptors have been implicated as ancient cellular sentinels mediating protective immune responses against intracellular pathogens. Recent studies have described the genetic association of polymorphisms in NOD-like receptor genes with complex chronic inflammatory barrier diseases, such as Crohn's disease and asthma and with rare auto-inflammatory syndromes including familial cold urticaria, Muckle-Wells syndrome and Blau syndrome. Whereas genetic variability in NLRs may have been an important element to provide plasticity to antigen recognition and host defense in the past, recent changes in the lifestyle of industrialized societies (e.g. hygiene ("cold-chain-hypothesis"), nutrition, or antibiotics) may have turned ancient genetic variability into disease-causing mutations. The review focuses on NLR function in the molecular pathophysiology of human inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376727     DOI: 10.1016/j.micinf.2007.01.015

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  27 in total

1.  Caspase recruitment domain-containing protein 8 (CARD8) negatively regulates NOD2-mediated signaling.

Authors:  Oliver von Kampen; Simone Lipinski; Andreas Till; Seamus J Martin; Wilfried Nietfeld; Hans Lehrach; Stefan Schreiber; Philip Rosenstiel
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

Review 2.  NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Authors:  Jeanette M Wilmanski; Tanja Petnicki-Ocwieja; Koichi S Kobayashi
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

Review 3.  [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement].

Authors:  M Laudien; P Ambrosch; A Till; R Podschun; P Lamprecht
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

4.  NLR functions beyond pathogen recognition.

Authors:  Thomas A Kufer; Philippe J Sansonetti
Journal:  Nat Immunol       Date:  2011-02       Impact factor: 25.606

Review 5.  Future biologic targets for IBD: potentials and pitfalls.

Authors:  Gil Y Melmed; Stephan R Targan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

6.  Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation.

Authors:  Xinjun Zhang; Hai Lin; Huiying Zhao; Yangyang Hao; Matthew Mort; David N Cooper; Yaoqi Zhou; Yunlong Liu
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

Review 7.  NLRC4/IPAF: a CARD carrying member of the NLR family.

Authors:  Fayyaz S Sutterwala; Richard A Flavell
Journal:  Clin Immunol       Date:  2008-09-25       Impact factor: 3.969

8.  NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma.

Authors:  Chun Kwok Wong; Shuiqing Hu; Karen Ming-Lam Leung; Jie Dong; Lan He; Yi Jun Chu; Ida Miu-Ting Chu; Huai-Na Qiu; Kelly Yan-Ping Liu; Christopher Wai-Kei Lam
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

9.  Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.

Authors:  Nikolaus Möckelmann; Witigo von Schönfels; Stephan Buch; Oliver von Kampen; Bence Sipos; Jan Hendrik Egberts; Philip Rosenstiel; Andre Franke; Mario Brosch; Sebastian Hinz; Christian Röder; Holger Kalthoff; Ulrich R Fölsch; Michael Krawczak; Stefan Schreiber; Clemens Dieter Bröring; Jürgen Tepel; Clemens Schafmayer; Jochen Hampe
Journal:  BMC Gastroenterol       Date:  2009-10-20       Impact factor: 3.067

10.  The expression of the beta-defensins hBD-2 and hBD-3 is differentially regulated by NF-kappaB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis.

Authors:  Nadine Steubesand; Karlheinz Kiehne; Gabriele Brunke; Rene Pahl; Karina Reiss; Karl-Heinz Herzig; Sabine Schubert; Stefan Schreiber; Ulrich R Fölsch; Philip Rosenstiel; Alexander Arlt
Journal:  BMC Immunol       Date:  2009-06-12       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.